Long Term Study of the Safety of OXC XR as in Pediatric Epilepsy Subjects
Clinical trial NCT00918424 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT00918424
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
- Start date
- 2009-06-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.